Every state sets its own deadline for filing a personal injury or product case — called the statute of limitations. For Olympus scope infection cases, those deadlines typically range from one to six years. Miss the deadline by a single day and most courts will permanently bar your case, no matter how strong it is.
But here is the part most patients do not know: the clock often does not start on the day of your procedure. It starts when you knew — or reasonably should have known — that a contaminated scope caused your infection. That difference can mean the difference between a closed door and an open case.
A statute of limitations is simply a deadline — the period a state gives a person to file a case after an injury. State deadlines vary, and which one applies to your case depends on facts the discovery rule controls (more on that in the next section). For most patients we talk to, the realistic deadline is much further out than the calendar might suggest.
Each state writes its own statute of limitations. There is no single national deadline. For Olympus scope infection cases, the deadline depends on three things:
For most scope cases the deadline lands somewhere between two and four years from the date of discovery, but a handful of states are shorter and a handful are longer. We will not pretend you can figure out the exact deadline by reading a website. The only safe answer is a free case review where an attorney looks at your specific timeline.
For an Olympus scope case, the discovery rule is usually the rule that matters most. In most states, the clock does not start on the day of your colonoscopy or ERCP. It starts when you knew, or reasonably should have known, that a defective scope caused your infection.
That distinction is critical because most patients are never told the scope was the source of their infection. After a hospital-acquired infection, doctors typically focus on treating the bacteria, not on tracing it back to a specific medical device. By the time the patient is well enough to ask questions, the procedure is months or years in the past.
Courts do not expect a patient to have figured out the scope connection on their own. A reasonable patient does not know that a duodenoscope has a sealed elevator channel that traps bacteria. A reasonable patient does not read FDA technical bulletins, congressional committee reports, or specialty medical journals. What courts ask is the practical question: when did this story become something an ordinary person could realistically have encountered?
For the patients we talk to, the honest answer is recently. The Olympus scope contamination story did not break into mainstream public awareness in any meaningful way until the FDA's June 24, 2025 import alert blocked 58 Olympus endoscope models from entering the United States. That federal action triggered the first real wave of consumer news coverage on these devices — local broadcast segments, national online outlets, and the personal-injury reporting that followed in 2025 and 2026. For most patients, that is when the story became visible.
Earlier regulatory milestones existed in the public record, and they are part of the factual foundation of the case. But they lived in places ordinary patients did not see — academic publications, FDA notices to industry, federal court filings, and congressional documents. None of that is the kind of material a patient at home recovering from a hospital-acquired infection is expected to have read. The discovery rule is built around what a reasonable patient could realistically have seen, not what a regulator, a journalist on a niche beat, or a lawyer would have known.
When your specific clock started is fact-by-fact. For most patients, the realistic discovery moment is the first time they saw a news article connecting Olympus scopes to infections like theirs — usually somewhere in 2025 or 2026. A patient who developed an infection years ago and only learned of the scope connection from recent news coverage is exactly the kind of case the discovery rule was written to protect. Whether your clock has started, and how much time you have left, is one of the first things we evaluate on the free case review call.
Even when the regular deadline looks like it has passed, several legal rules can keep a case alive. None of these are automatic. Each one has to be argued and proven. But each one has been used successfully in product liability cases against medical device companies.
When a manufacturer hides what it knows from regulators and patients, courts in most states pause the clock for as long as the concealment kept ordinary patients in the dark. Federal records reflect years of Olympus failing to report scope-related harms to U.S. regulators — the kind of corporate conduct that supports this tolling argument and that ordinary patients had no realistic way to learn about until consumer news coverage broke in 2025 and 2026.
When the injured patient was a minor at the time of the procedure, most states pause the clock until the patient turns 18. The full deadline does not start until adulthood. Pediatric scope infections are rare but they do happen and the rule matters in those cases.
When a patient dies from a scope-related infection, the family's wrongful death case has its own deadline that usually runs from the date of death, not the date of the procedure. This is why a death many years after the original infection can sometimes still support a timely case.
In a few states, when a patient has been receiving ongoing treatment for the infection, courts will pause the clock until that treatment ends. This rule is more common in malpractice law than product law but it can apply when both kinds of claims are filed in the same case.
Almost no one we talk to knew about the Olympus scope contamination problem at the time of their procedure. The story did not break into mainstream news in any meaningful way until the FDA's June 24, 2025 import alert blocked 58 Olympus scope models from entering the United States. That federal action drove the first real wave of consumer news coverage — local broadcast, national online outlets, and personal-injury reporting throughout 2025 and 2026 — that gave ordinary patients a realistic way to connect their infection to a contaminated device. For most patients, that recent coverage is when the story finally became visible.
That is exactly the situation the discovery rule is built for. In most states, your filing clock does not start when the procedure happened — it starts when you knew, or reasonably should have known, that a defective scope was the cause. For patients who only learned the truth from recent coverage, the deadline that looks long-passed on paper is often still wide open. A case that feels too old to bring may very well still be in time.
Do not try to pull your own medical records. Do not try to identify the scope. Do not try to apply your state's deadline to your facts. All of that is on us. Once we open your file, we send out the HIPAA records requests, identify the device that was used, build the timeline, and lock in the filing window — at our expense, on contingency, with no fee unless we recover money for you.
Free, confidential, no obligation. We answer the phone in English and Spanish.
A free case review takes 10 to 20 minutes by phone. We listen to what happened, evaluate how the discovery rule applies to your facts, and give you a straight answer about whether you are still in time. If the case fits, we begin work that same day — pulling records, identifying the scope, and protecting the filing window before the calendar can run out in the background.
The discovery rule gives most patients more time than they realize. But the moment to use that time is now, while we can still build the case. Every week of delay is a week we do not get back — and the case we can win for you depends on the records we are able to gather.
The questions we hear most often from patients and families trying to figure out whether they are still in time to file.
Every state sets its own deadline. The most common range for product liability and personal injury cases is one to six years, with most states landing somewhere between two and four years. The deadline that applies to your case depends on the state where the procedure happened, the state where you live, and the type of case being filed. The only way to know your exact deadline is to have a lawyer review the facts of your case. A free case review costs nothing and is the fastest way to find out.
In most states, the clock starts on what is called the date of discovery — the date you knew, or reasonably should have known, that a defective scope caused your infection. The Olympus scope contamination story did not break into mainstream consumer news until the FDA's June 24, 2025 import alert and the wave of public reporting that followed in 2025 and 2026. For most patients, that is when a reasonable person could first have connected their infection to a contaminated device. The federal record of years-long corporate concealment by Olympus supports a delayed-discovery argument that often keeps the filing window open well past the date of the procedure.
Not necessarily. Even if your procedure was five, six, or more years ago, the discovery rule may keep your filing window open. Patients who only recently connected their infection to a contaminated scope — usually through news coverage in 2025 or 2026, a family member who saw a story, or a conversation with a lawyer — may still be in time. The only way to know is to have an attorney review your timeline and the state law that applies. There is no cost or obligation to find out.
When a patient dies from a scope-related infection, the family or estate may bring what is called a wrongful death case. Wrongful death cases have their own filing deadlines that are usually different from — and often shorter than — ordinary personal injury deadlines. They typically run from the date of death rather than the date of injury. If a family member died after an endoscopic procedure, do not wait to call. The wrongful death window in some states is as short as one year.
No. A regulatory action like the FDA's June 2025 import alert does not by itself reset or extend any state's filing deadline. What it can do is reinforce the discovery argument: a federal regulatory finding that Olympus scopes were unsafe is exactly the kind of public information that helps establish when a reasonable patient could first have connected their infection to the device. But the import alert is supporting evidence, not an automatic deadline reset. The calendar still controls.
Every factual claim on this page is supported by a verifiable public source. Click any source below to read the original.
Last reviewed:
Browse the full library of contaminated endoscope and Olympus scope investigation pages.
Start here — overview of contaminated endoscope litigation.
How design flaws turn scopes into superbug carriers.
Colonoscopy, ERCP, bronchoscopy, upper endoscopy — what's at risk.
Timeline of FDA recalls, warnings, and import alerts.
CRE, MDRO, sepsis warning signs to watch for.
The closed-channel elevator that resists sterilization.
Duodenoscope-linked outbreaks and ERCP claims.
When routine screenings cause hospital-acquired infections.
Cleaning shortcuts that put patients at risk.
Find out in 60 seconds if you have a case.
Latest FDA actions, MDL updates, and case news.
What the June 2025 FDA Olympus import alert means for patients.
Did Olympus meet its FDA deadline? 96% completion claim, Canadian class action, and what's still outstanding.
Where Olympus scope cases stand: no MDL yet, individual filings, deadline pressure.
The drug-resistant bacteria documented in scope outbreaks, in plain English.
How to find out which scope was used on you and what records to request.
Olympus bronchoscope cases — pneumonia, sepsis, who qualifies.
Was your hospital part of an Olympus scope outbreak?
Records and documentation that build a strong scope case.
Why scope cases are usually product liability, not malpractice.
No fees unless we recover money for you — how it works.
If you developed a serious infection after an endoscopic procedure, do not assume the deadline has passed. The discovery rule keeps many older cases alive, and the only way to know is to ask. A free case review costs you nothing. No Fees Unless We Recover Money for You.
